Niki BioSolutions regains Nasdaq listing compliance
Rhea-AI Filing Summary
Niki BioSolutions, Inc., formerly known as Aptorum Group Limited, had previously been notified that its common stock traded below the $1.00 per share minimum bid price for 30 consecutive business days, triggering a deficiency under Nasdaq Listing Rule 5550(a)(2). The company was granted a 180‑day compliance period ending on September 1, 2026, during which it could regain compliance by maintaining a closing bid of at least $1.00 for ten consecutive business days.
Nasdaq subsequently informed the company on August 4, 2026 that, from July 21, 2026 to August 3, 2026, the closing bid price of its common stock was at or above $1.00 per share for ten consecutive business days. As a result, Niki BioSolutions has regained compliance with Nasdaq Listing Rule 5550(a)(2), and Nasdaq has indicated that this matter is now closed.
Positive
- Niki BioSolutions has regained compliance with Nasdaq Listing Rule 5550(a)(2) after its stock maintained a closing bid of at least $1.00 per share for 10 consecutive business days, and Nasdaq has confirmed the matter is closed.
Negative
- None.
8-K Event Classification
Item 8.01 — Other Events
1 item
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Key Figures
Minimum bid price requirement: $1.00 per share
Noncompliance trigger period: 30 consecutive business days
Compliance period length: 180 calendar days
+2 more
5 metrics
Minimum bid price requirement
$1.00 per share
Required minimum bid under Nasdaq Listing Rule 5550(a)(2) for continued listing
Noncompliance trigger period
30 consecutive business days
Period during which the stock closed below $1.00 per share before deficiency notice
Compliance period length
180 calendar days
Time allowed to regain compliance, ending September 1, 2026
Regaining compliance condition
10 consecutive business days
Required span with closing price at or above $1.00 per share to regain compliance
Compliance achievement window
July 21, 2026 to August 3, 2026
Dates when closing bid price was at or above $1.00 per share
Key Terms
Nasdaq Listing Rule 5550(a)(2), minimum bid price requirement, Nasdaq Capital Market, Listing Qualifications Department
4 terms
Nasdaq Listing Rule 5550(a)(2) regulatory
"the minimum $1.00 per share required for continued listing under Nasdaq Listing Rule 5550(a)(2)"
minimum bid price requirement market
"below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market"
A minimum bid price requirement is a rule that a stock must trade above a set price for a specified period to stay listed on an exchange. It matters to investors because falling below that threshold can trigger warnings or removal from the exchange, which can cut liquidity, reduce visibility, and often lead to sharper declines in share value—think of it like a venue’s minimum dress code that, if not met, can bar a performer from the stage.
Nasdaq Capital Market market
"continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2)"
The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.
Listing Qualifications Department regulatory
"received a deficiency letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC"
A listing qualifications department is the part of a stock exchange that checks whether a company meets the exchange’s rules for being listed and staying listed. Think of it as a gatekeeper or building inspector: it reviews financial statements, disclosure practices and corporate governance, flags problems and can require fixes or remove a company’s shares. Investors care because its decisions affect whether a stock remains tradable and how much trust to place in a company’s reporting.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Niki BioSolutions disclose that affects APM investors?
Niki BioSolutions disclosed that it has regained compliance with Nasdaq’s $1.00 minimum bid price requirement after meeting the 10 consecutive business day closing bid condition, and Nasdaq has confirmed the compliance issue is closed.
Why was Niki BioSolutions (APM) previously out of compliance with Nasdaq rules?
The company was previously out of compliance because its common stock closed below $1.00 per share for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2) regarding the minimum bid price for continued listing.
What was the compliance period Nasdaq gave Niki BioSolutions (APM)?
Nasdaq granted a 180‑calendar‑day compliance period, running until September 1, 2026, during which Niki BioSolutions could regain compliance by achieving a closing bid price of at least $1.00 for ten consecutive business days.
How did Niki BioSolutions (APM) regain compliance with the Nasdaq bid rule?
The company regained compliance after its common stock’s closing bid price was at or above $1.00 per share for 10 consecutive business days, from July 21, 2026 through August 3, 2026, meeting Nasdaq’s specified condition.
What Nasdaq rule is relevant to Niki BioSolutions’ (APM) listing status?
The relevant rule is Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market; the company has now regained compliance with this rule.
AI-generated analysis. How Rhea-AI works. Not financial advice.
